首发精神病停用抗精神病药后精神病性复发的多巴胺失调:[18F]DOPA与[11C]raclopride PET研究
该研究纳入25例临床稳定的首发精神病患者和14名匹配健康对照,在停用抗精神病药前及停药6周后行[18F]DOPA PET评估纹状体多巴胺活性,停药后行[11C]raclopride PET评估D2/3受体可用性,并随访12周监测精神病性复发。40%患者停药后复发,复发、未复发患者与健康对照的Kicer值随时间变化显著不同,复发患者基线纹状体Kicer值与停药至复发时间显著相关,BPND三组间无显著差异。结果提示多巴胺自身调节功能障碍可能促发停药后复发。
要点
- 40%首发精神病患者停用抗精神病药后12周内出现精神病性复发。
- 复发、未复发患者与健康对照的纹状体Kicer值随时间变化显著不同。
- 复发患者基线纹状体Kicer值与停药至复发时间显著相关。
核心结论
- 多巴胺自身调节功能障碍可能促发首发精神病患者停用抗精神病药后的精神病性复发。
研究设计与样本
- 研究纳入25例临床稳定的首发精神病患者和14名匹配的健康对照。
- 在停用抗精神病药前和停药6周后行[18F]DOPA PET评估纹状体多巴胺活性(Kicer值)。
- 停药后行[11C]raclopride PET评估D2/3受体可用性(BPND),健康对照按相应时间表接受PET扫描。
- 停药后随访12周监测精神病性复发。
主要发现
- 40%的患者在停用抗精神病药后出现精神病性复发。
- 复发患者、未复发患者和健康对照的Kicer值随时间变化显著不同(Week*Group: F = 4.827, df = 2,253.193, p = 0.009)。
- 在复发患者中,基线纹状体Kicer值与停用抗精神病药后至复发的时间显著相关(R2 = 0.518, p = 0.018)。
- 复发患者、未复发患者和健康对照之间的BPND无显著差异(F = 1.402, df = 2,32.000, p = 0.261)。
临床怎么用
- 基线纹状体多巴胺活性可能有助于识别停用抗精神病药后复发风险较高的首发精神病患者。
- 该发现可能用于制定与停用抗精神病药相关的精神病性复发预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although antipsychotic drugs are effective for relieving the psychotic symptoms of first-episode psychosis (FEP), psychotic relapse is common during the course of the illness. While some FEPs remain remitted even without medication, antipsychotic discontinuation is regarded as the most common risk factor for the relapse. Considering the actions of antipsychotic drugs on presynaptic and postsynaptic dopamine dysregulation, this study evaluated possible mechanisms underlying relapse after antipsychotic discontinuation. Twenty five FEPs who were clinically stable and 14 matched healthy controls were enrolled. Striatal dopamine activity was assessed as Kicer value using [18F]DOPA PET before and 6 weeks after antipsychotic discontinuation. The D2/3 receptor availability was measured as BPND using [11C]raclopride PET after antipsychotic discontinuation. Healthy controls also underwent PET scans according to the corresponding schedule of the patients. Patients were monitored for psychotic relapse during 12 weeks after antipsychotic discontinuation. 40% of the patients showed psychotic relapse after antipsychotic discontinuation. The change in Kicer value over time significantly differed between relapsed, non-relapsed patients and healthy controls (Week*Group: F = 4.827, df = 2,253.193, p = 0.009). In relapsed patients, a significant correlation was found between baseline striatal Kicer values and time to relapse after antipsychotic discontinuation (R2 = 0.518, p = 0.018). BPND were not significantly different between relapsed, non-relapsed patients and healthy controls (F = 1.402, df = 2,32.000, p = 0.261). These results suggest that dysfunctional dopamine autoregulation might precipitate psychotic relapse after antipsychotic discontinuation in FEP. This finding could be used for developing a strategy for the prevention of psychotic relapse related to antipsychotic discontinuation.
引用
- Kim S, Shin SH, Santangelo B, et al. Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [18F]DOPA and [11C]raclopride PET study in first-episode psychosis. Mol Psychiatry. 2020. PMID: 32929214. doi:10.1038/s41380-020-00879-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。